OPIANT PHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q3 2022

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Opiant Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q3 2022.
  • Opiant Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 10, 2022 was 5.17M shares, a 9.48% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 5.17M +448K +9.48% Nov 10, 2022 10-Q 2022-11-14
Q2 2022 5.16M +764K +17.4% Aug 8, 2022 10-Q 2022-08-11
Q1 2022 5.07M +778K +18.1% Mar 14, 2022 10-K 2022-03-15
Q3 2021 4.72M +462K +10.9% Nov 9, 2021 10-Q 2021-11-12
Q2 2021 4.4M +142K +3.33% Aug 2, 2021 10-Q 2021-08-05
Q1 2021 4.29M +53K +1.25% Mar 1, 2021 10-K 2021-03-04
Q3 2020 4.26M +163K +3.99% Nov 9, 2020 10-Q 2020-11-12
Q2 2020 4.26M +217K +5.37% Aug 5, 2020 10-Q 2020-08-06
Q1 2020 4.24M +313K +7.98% Mar 2, 2020 10-K 2020-03-04
Q3 2019 4.09M +260K +6.78% Nov 7, 2019 10-Q 2019-11-12
Q2 2019 4.04M +1.22M +43.2% Aug 5, 2019 10-Q 2019-08-08
Q1 2019 3.93M +1.39M +54.7% Mar 15, 2019 10-K 2019-03-21
Q3 2018 3.83M +1.8M +88.2% Nov 5, 2018 10-Q 2018-11-07
Q2 2018 2.82M +796K +39.3% Aug 3, 2018 10-Q 2018-08-09
Q1 2018 2.54M +501K +24.6% Mar 6, 2018 10-KT 2018-03-07
Q4 2017 2.07M +31K +1.52% Dec 1, 2017 10-Q 2017-12-04
Q3 2017 2.04M +16.3K +0.81% Oct 10, 2017 10-K 2017-10-13
Q2 2017 2.03M +38.9K +1.96% Jun 6, 2017 10-Q 2017-06-14
Q1 2017 2.04M +124K +6.48% Mar 7, 2017 10-Q 2017-03-15
Q4 2016 2.04M +151K +8% Dec 5, 2016 10-Q 2016-12-15
Q3 2016 2.02M +150K +8% Oct 17, 2016 10-K 2016-10-28
Q2 2016 1.99M +140K +7.6% Jun 8, 2016 10-Q 2016-06-08
Q1 2016 1.91M +85.4K +4.67% Mar 11, 2016 10-Q 2016-03-15
Q4 2015 1.89M -180M -99% Dec 9, 2015 10-Q 2015-12-14
Q3 2015 1.87M -178M -99% Oct 20, 2015 10-K 2015-10-26
Q2 2015 1.85M -176M -99% Jun 9, 2015 10-Q 2015-06-12
Q1 2015 1.83M -176M -99% Mar 12, 2015 10-Q 2015-03-17
Q4 2014 182M +6.31M +3.59% Dec 5, 2014 10-Q 2014-12-09
Q3 2014 180M +10.8M +6.4% Oct 23, 2014 10-K 2014-10-27
Q2 2014 178M +22.6M +14.6% Jun 6, 2014 10-Q 2014-06-10
Q1 2014 178M +38.1M +27.3% Mar 11, 2014 10-Q 2014-03-17
Q4 2013 176M Dec 12, 2013 10-Q 2013-12-16
Q3 2013 169M +38.2M +29.2% Oct 23, 2013 10-K 2013-10-29
Q2 2013 155M +29.2M +23.2% Jun 14, 2013 10-Q 2013-06-14
Q1 2013 139M +22.1M +18.8% Mar 18, 2013 10-Q 2013-03-18
Q3 2012 131M +38.6M +42% Oct 31, 2012 10-Q 2012-12-20
Q2 2012 126M Jul 31, 2012 10-K/A 2012-11-01
Q1 2012 117M Apr 30, 2012 10-Q 2012-06-14
Q4 2011 104M Jan 31, 2012 10-Q 2012-03-16
Q3 2011 92M Oct 31, 2011 10-Q 2011-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.